Health Reference LibraryHydroxocobalamin B12: what it is and when to choose it
This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Summary
Hydroxocobalamin is the vitamin B12 form the NHS uses for injections: for deficiency not caused by diet, the standard pattern is an injection every 2 to 3 months for life, arranged by a GP. As an oral supplement it is a precursor form the body converts into both active coenzymes, and the NIH Office of Dietary Supplements states no evidence shows supplement absorption varies by B12 form, so choosing hydroxocobalamin by mouth is about wanting the NHS-used molecule, not better absorption. Passive absorption of large oral doses runs at roughly 1 to 2%, which is why oral protocols use 1000mcg or more against a daily reference intake of 1.5mcg.
How it works
Hydroxocobalamin is a precursor form of vitamin B12. Once absorbed, cells strip and rebuild any cobalamin into the same two active coenzymes, methylcobalamin in the cytosol and adenosylcobalamin in mitochondria, so the labelled form on the bottle is not the form doing the work. Hydroxocobalamin binds strongly to plasma proteins, which is part of why it is the form used for long-interval NHS injections.
Effective dose
Active absorption through intrinsic factor saturates at roughly 1.5 to 2mcg per dose, and beyond that only a small passive fraction gets through: about 2% at 500mcg and 1.3% at 1000mcg per the NIH ODS figures. That arithmetic is why everyday maintenance needs only the UK reference intake of 1.5mcg while oral correction protocols reviewed by the NIH ODS used 1000 to 2000mcg daily. Dose does the work; form does not.
Forms compared
Four supplement forms exist: cyanocobalamin, methylcobalamin, adenosylcobalamin and hydroxocobalamin. Hydroxocobalamin is the one the NHS injects. For oral supplements the NIH Office of Dietary Supplements is explicit that no evidence indicates absorption varies by form, so the honest reasons to pick oral hydroxocobalamin are preference for the NHS-used molecule and wanting a single precursor form without choosing between the two coenzyme forms. The full four-way comparison lives in the buying guide in this library.
Timing
Any time of day, with or without food. Supplemental B12 is free cobalamin and does not depend on stomach acid the way food-bound B12 does. Consistency matters more than clock time.
Safety profile
No UK or EU upper intake level is set for vitamin B12 and excess is excreted in urine. High oral doses across the trial literature carry a benign record. Injections sit outside self-supplementation entirely and are prescribed and scheduled by a GP.
Special populations
Deficiency not caused by diet, including pernicious anaemia, is GP territory under NICE NG239, and the NHS pattern for it is a hydroxocobalamin injection every 2 to 3 months for life. Neurological symptoms such as numbness or tingling in the hands and feet make the GP conversation urgent, because injection frequency is set differently while symptoms are improving. Vegans, adults over 65, and people on long-term metformin or acid suppressants carry higher deficiency risk and benefit from testing before supplementing.
Interactions
Long-term metformin lowers B12 absorption, and proton pump inhibitors and H2 blockers reduce absorption of food-bound B12 specifically; both groups are flagged for periodic testing in the NIH ODS professional fact sheet. No food separation rules apply to the supplement itself.
Guideline positions
NICE NG239 (2024): intramuscular hydroxocobalamin is the UK route for confirmed deficiency, with GP-led diagnosis and scheduling. NHS guidance: for B12 deficiency not caused by diet, an injection of hydroxocobalamin every 2 to 3 months for life is the standard maintenance pattern. NIH ODS professional fact sheet (updated July 2025): no evidence that supplement absorption varies by B12 form; passive absorption roughly 2% at 500mcg and 1.3% at 1000mcg; oral 1000 to 2000mcg daily protocols reviewed as comparable to injections in selected cases.
Practical framework
Sort yourself into one of three lanes. Confirmed or suspected deficiency, especially with neurological symptoms or pernicious anaemia: GP first, because injections and their schedule are prescribed, not bought. Maintenance on a plant-based or low-animal-food diet: any form at a modest dose does the job, and hydroxocobalamin is a clean choice if you want the NHS-used molecule; a single-form hydroxocobalamin liquid is the worked example on our shelf at nutritailor.co.uk/products/vitamin-b12-hydroxocobalamin. Unsure which lane you are in: a serum B12 test with your GP or a home panel settles it before any purchase.
Common misconceptions
That oral hydroxocobalamin recreates the injections: the molecule matches but the route, dose and clinical supervision do not, and non-dietary deficiency still belongs with a GP. That hydroxocobalamin absorbs better than other oral forms: the NIH ODS states no form difference exists, and the passive-absorption arithmetic applies to all four equally. That an injection form must beat tablets generally: reviewed oral high-dose protocols performed comparably in selected cases, which is a statement about dose, not form.
Sources
- National Institute for Health and Care Excellence (NICE, UK government) 2024. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239). National Institute for Health and Care Excellence (NICE).
- NHS (UK government) 2025. Vitamin B12 or folate deficiency anaemia: what happens at your appointments (NHS). NHS.uk.
- NIH Office of Dietary Supplements 2025. Vitamin B12: Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements.